These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1349855

  • 1. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS, Hirokawa WT.
    Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 3. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994 Mar; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

  • 4. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
    Westheim A, Daae LN, Kierulf P, Brusletto B, Holme I, Syvertsen JO.
    J Hypertens Suppl; 1990 Sep; 8(5):S41-6. PubMed ID: 1981076
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Talseth T, Westlie L, Daae LN.
    J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
    [Abstract] [Full Text] [Related]

  • 6. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
    J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.
    Hamilton CA, Reid JL, Vincent J.
    Br J Pharmacol; 1985 Sep; 86(1):79-87. PubMed ID: 2864970
    [Abstract] [Full Text] [Related]

  • 9. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Young RA, Brogden RN.
    Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495
    [Abstract] [Full Text] [Related]

  • 10. [Doxazosin for the treatment of arterial hypertension].
    Mozzato MG, Semplicini A, Serena L, Valle R, Casolino P, Buzzaccarini F, Rubino N, Giusto M, Pessina AC.
    Cardiologia; 1990 Nov; 35(11):931-6. PubMed ID: 2151571
    [Abstract] [Full Text] [Related]

  • 11. Clinical pharmacotherapeutics of doxazosin.
    Taylor SH.
    Am J Med; 1989 Aug 16; 87(2A):2S-11S. PubMed ID: 2569822
    [Abstract] [Full Text] [Related]

  • 12. Metabolic changes during antihypertensive therapies.
    Krone W, Nägele H.
    J Hum Hypertens; 1989 Dec 16; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
    [Abstract] [Full Text] [Related]

  • 13. Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins.
    Ames RP, Kiyasu JY.
    J Clin Pharmacol; 1989 Feb 16; 29(2):123-7. PubMed ID: 2565917
    [Abstract] [Full Text] [Related]

  • 14. Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents.
    Louis WJ, McNeil JJ, Anavekar SN, Conway EL, Workman B, Howes LG, Drummer OH, Jarrott B.
    J Cardiovasc Pharmacol; 1987 Feb 16; 10 Suppl 12():S100-3. PubMed ID: 2455158
    [Abstract] [Full Text] [Related]

  • 15. Effects of alpha 1-inhibition on lipid metabolism in the rat.
    Woodside WF, Swindell AC.
    J Cardiovasc Pharmacol; 1987 Feb 16; 10 Suppl 9():S27-34. PubMed ID: 2447438
    [Abstract] [Full Text] [Related]

  • 16. Effects of oral antihypertensive agents on blood lipid levels.
    Leren P.
    Clin Ther; 1986 Feb 16; 8(3):309-19. PubMed ID: 2872961
    [Abstract] [Full Text] [Related]

  • 17. Effects of doxazosin on vascular collagen synthesis, arterial pressure and serum lipids in the spontaneously hypertensive rat.
    Chichester CO, Rodgers RL.
    J Cardiovasc Pharmacol; 1987 Feb 16; 10 Suppl 9():S21-6. PubMed ID: 2447437
    [Abstract] [Full Text] [Related]

  • 18. Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model.
    Foxall TL, Shwaery GT, Stucchi AF, Nicolosi RJ, Wong SS.
    Am J Pathol; 1992 Jun 16; 140(6):1357-63. PubMed ID: 1351367
    [Abstract] [Full Text] [Related]

  • 19. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
    Pessina AC.
    Clin Ter; 1995 Jan 16; 146(1):3-12. PubMed ID: 7705011
    [Abstract] [Full Text] [Related]

  • 20. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Jan 16; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.